JPRN-UMIN000032014Completed未知
To identify the presence of type 2 diabetes patients with elevated insulin clearance and clarify there clinical characteristics. - Identification of the presence of type 2 diabetes patients with elevated insulin clearance
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Jinnouchi Hospital
- Enrollment
- 101
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •ketoacidosis, pregnancy, cancer, thyroid disease, adrenal tumor, renal failure, active infection, inflammatory disease, autoimmune disease, liver cirrhosis, Viral hepatitis, dementia, schizophrenia, and those who did not accept to have hyperinsulinemic-euglycemic clamp examination.
Investigators
Similar Trials
Completed
Not Applicable
EXERFLOW STUDY:The effects of aerobic and resistance exercise training on vascular endothelial function in people with type 2 diabetes mellitusType 2 diabetesVascular function (endothelial function)Metabolic and Endocrine - DiabetesCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12609000799257Baker IDI Heart and Diabetes Institute45
Active, not recruiting
Not Applicable
Development of a non-invasive and accurate diagnostic method for type 2 diabetes using acetone in urine samplesType 2 diabetesNutritional, Metabolic, EndocrineType 2 diabetes mellitusISRCTN12308193Hefei Institutes of Physical Science400
Not yet recruiting
Not Applicable
‘Stepping up’ exercise for type 2 diabetes: a stepped care approach to lifestyle therapytype 2 diabetesMetabolic and Endocrine - DiabetesMetabolic and Endocrine - Other metabolic disordersPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationObesityACTRN12620000027910The University of Queensland80
Recruiting
Not Applicable
Saiseikai observational study of type 2 diabetics with microangiopathy in relation to macroangiopathyType 2 diabetesJPRN-UMIN000006247SDMac Study Group200
Completed
Phase 3
Double blind, randomised, comparative, multicentre, parallel-group study design to evaluate the effects of Pioglitazone on cardiovascular risk markers in type 2 diabetes mellitusACTRN12608000534381Takeda Italia Farmaceutici S.p.A.100